MEI Pharma, Inc.

MEIPNASDAQHealthcare

$3.07

+$0.29(+10.43%)

Market Cap$20452012

P/E Ratio—

52W High$9

52W Low$1.46

Avg Volume1.5M

Open$2.89

Beta0.22

Insider Trades Ownership Employees

MEI Pharma, Inc. (MEIP) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · MEIP · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

3.00

Buy/Sell (by trades)

Overall sentiment

BULLISH

↑ Buy 75%Active transactions only · RSU vesting excluded25% Sell ↓

MEI Pharma, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

MEIP insider buying and selling by quarter

MEIP insider selling · MEIP insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

6.2M3.1M0

2021 Q4

2022 Q3

2023 Q1

2023 Q2

2023 Q3

2023 Q4

2024 Q2

2025 Q3

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Recent insider transactions

MEIP executive sell shares · MEIP board member insider trading · MEIP insider trading SEC filing

Showing 19 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
May 17, 2024	Wood Steven D Director	Award	3,100	$3.17	$10K	4,359	Form 4
May 16, 2024	Flynn James P Director	Award	7,900	$3.16	$25K	7,900	Form 4
Oct 20, 2023	Funicular Funds, LP 10 percent owner	Other	120,600	$7.00	$844K	611,440	Form 4
Oct 20, 2023	Anson Funds Management LP 10 percent owner	Other	35,800	$7.00	$251K	1,093,188	Form 4
Oct 20, 2023	Anson Funds Management LP 10 percent owner	Other	143,200	$7.00	$1.00M⚡	1,057,388	Form 4
Oct 11, 2023	Funicular Funds, LP 10 percent owner	Other	30,000	$7.00	$210K	490,840	Form 4
Oct 11, 2023	Anson Funds Management LP 10 percent owner	Other	10,000	$7.00	$70K	914,188	Form 4
Oct 11, 2023	Anson Funds Management LP 10 percent owner	Other	40,000	$7.00	$280K	904,188	Form 4
Sep 22, 2023	Anson Funds Management LP 10 percent owner	Purchase	48,060	$6.85	$329K	864,188	Form 4
Sep 22, 2023	Funicular Funds, LP 10 percent owner	Purchase	32,040	$6.85	$220K	460,840	Form 4
Sep 21, 2023	Anson Funds Management LP 10 percent owner	Purchase	33,600	$6.46	$217K	816,128	Form 4
Sep 20, 2023	Anson Funds Management LP 10 percent owner	Purchase	120,000	$6.01	$721K	782,528	Form 4
Sep 21, 2023	Funicular Funds, LP 10 percent owner	Purchase	22,400	$6.46	$145K	428,800	Form 4
Sep 20, 2023	Funicular Funds, LP 10 percent owner	Purchase	80,000	$6.01	$481K	406,400	Form 4
Feb 28, 2023	Baltic Charles V. III Director	Purchase	81,500	$0.23	$18K	105,750	Form 4
Jul 5, 2022	GHALIE RICHARD G Chief Medical Officer	Other	8,196	$0.54	$4K	28,927	Form 4
Jul 2, 2021	Urso David M Chief Operating Officer & GC	Other	24,825	$2.94	$73K	49,281	Form 4
Jul 2, 2021	GOLD DANIEL P PHD CEO · Director	Other	41,320	$2.94	$121K	417,312	Form 4
May 25, 2021	GOLD DANIEL P PHD CEO · Director	Option	5,000	$2.52	$13K	458,632	Form 4

Wood Steven D

Director

Award

Date

May 17

3,100

Price

$3.17

Value

$10K

View Form 4 on SEC.gov

Flynn James P

Director

Award

Date

May 16

7,900

Price

$3.16

Value

$25K

View Form 4 on SEC.gov

Funicular Funds, LP

10 percent owner

Other

Date

Oct 20

120,600

Price

$7.00

Value

$844K

View Form 4 on SEC.gov

Anson Funds Management LP

10 percent owner

Other

Date

Oct 20

35,800

Price

$7.00

Value

$251K

View Form 4 on SEC.gov

Anson Funds Management LP

10 percent owner

Other

Date

Oct 20

143,200

Price

$7.00

Value

$1.00M ⚡

View Form 4 on SEC.gov

Funicular Funds, LP

10 percent owner

Other

Date

Oct 11

30,000

Price

$7.00

Value

$210K

View Form 4 on SEC.gov

Anson Funds Management LP

10 percent owner

Other

Date

Oct 11

10,000

Price

$7.00

Value

$70K

View Form 4 on SEC.gov

Anson Funds Management LP

10 percent owner

Other

Date

Oct 11

40,000

Price

$7.00

Value

$280K

View Form 4 on SEC.gov

Anson Funds Management LP

10 percent owner

Purchase

Date

Sep 22

48,060

Price

$6.85

Value

$329K

View Form 4 on SEC.gov

Funicular Funds, LP

10 percent owner

Purchase

Date

Sep 22

32,040

Price

$6.85

Value

$220K

View Form 4 on SEC.gov

Anson Funds Management LP

10 percent owner

Purchase

Date

Sep 21

33,600

Price

$6.46

Value

$217K

View Form 4 on SEC.gov

Anson Funds Management LP

10 percent owner

Purchase

Date

Sep 20

120,000

Price

$6.01

Value

$721K

View Form 4 on SEC.gov

Funicular Funds, LP

10 percent owner

Purchase

Date

Sep 21

22,400

Price

$6.46

Value

$145K

View Form 4 on SEC.gov

Funicular Funds, LP

10 percent owner

Purchase

Date

Sep 20

80,000

Price

$6.01

Value

$481K

View Form 4 on SEC.gov

Baltic Charles V. III

Director

Purchase

Date

Feb 28

81,500

Price

$0.23

Value

$18K

View Form 4 on SEC.gov

GHALIE RICHARD G

Chief Medical Officer

Other

Date

Jul 5

8,196

Price

$0.54

Value

$4K

View Form 4 on SEC.gov

Urso David M

Chief Operating Officer & GC

Other

Date

Jul 2

24,825

Price

$2.94

Value

$73K

View Form 4 on SEC.gov

GOLD DANIEL P PHD

CEO · Director

Other

Date

Jul 2

41,320

Price

$2.94

Value

$121K

View Form 4 on SEC.gov

GOLD DANIEL P PHD

CEO · Director

Option

Date

May 25

5,000

Price

$2.52

Value

$13K

View Form 4 on SEC.gov

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About MEIP insider trading

MEIP insider trades

MEI Pharma, Inc. (MEIP) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including MEIP. Over the past 12 months, 0 insiders have filed transactions with the SEC. MEIP insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For MEI Pharma, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

MEIP insider trading · 5 questions

The insiders of MEI Pharma, Inc. (MEIP) include executives and directors such as MEIP, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

MEIP board member insider tradingwho are MEIP insidersMEIP insider rosterMEI Pharma, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026